FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harry de Koning

Research Profile

Procedures

Geographic Areas

Disorders

Chemicals & Drugs

Prostate Specific Antigen

Concepts & Ideas

Activities & Behaviors

Co-author Network

Publications

TOP 3
Ruth Etzioni; Eric J Feuer; Roman Gulati; E A M Heijnsdijk; Jeffrey Katcher; Harry J de Koning; Gerrit Draisma; David F Penson; Alexander Tsodikov; Elisabeth M Wever; Angela B Mariotto
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.
Heleen van Agt; Annemieke van der Steen; Jacques Fracheboud; Harry J de Koning
Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination.
Angela M Tjiam; Elizabet Vukovic; Wijnanda L Asjes-Tydeman; Gerard J J M Borsboom; Harry J de Koning; Gerdien Holtslag; Sjoukje E Loudon; Huibert J Simonsz
An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harry de Koning (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ruth Etzioni; Eric J Feuer; Roman Gulati; E A M Heijnsdijk; Jeffrey Katcher; Harry J de Koning; Gerrit Draisma; David F Penson; Alexander Tsodikov; Elisabeth M Wever; Angela B Mariotto
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.
Cancer 2012;118(23):5955-63.
2012: Heleen van Agt; Annemieke van der Steen; Jacques Fracheboud; Harry J de Koning
Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination.
Patient education and counseling 2012;89(2):353-9.
2012: Angela M Tjiam; Elizabet Vukovic; Wijnanda L Asjes-Tydeman; Gerard J J M Borsboom; Harry J de Koning; Gerdien Holtslag; Sjoukje E Loudon; Huibert J Simonsz
An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants.
Ophthalmology 2012;119(11):2393-401.
2012: Roderick C N van den Bergh; Chris H Bangma; Harry J de Koning; Ida J Korfage; Monique J Roobol; Ewout W Steyerberg; Marie-Louise Essink-Bot
Sexual function with localized prostate cancer: active surveillance vs radical therapy.
BJU international 2012;110(7):1032-9.
2012: Eveline C F M Louwers; Badies H A N Manaï; Henriëtte A Moll; Madelon Ruige; Dop J H Scheewe; Arianne H Teeuw; Marjolijn H van de Merwe; Annette P M van den Elzen; Anne-Françoise S R Vooijs-Moulaert; Marjo J Affourtit; Adriaan N Bosschaart; Mieke H T M Jongejan; Ida J Korfage; Caspar W N Looman; Harry J de Koning
Effects of systematic screening and detection of child abuse in emergency departments.
Pediatrics 2012;130(3):457-64.
2012: E A M Heijnsdijk; Kimberly A Hill; Nicoline Hoogerbrugge; Maartje J Hooning; Reini Kaas; Jan G M Klijn; Martin O Leach; Jan C Oosterwijk; Don B Plewes; Elizabeth A Ramsay; Emiel J T Rutgers; Madeleine M A Tilanus-Linthorst; Ellen Warner; Ruth M L Warren; Martin N J M Wasser; Gerrit Draisma; Rosalind A Eeles; Gareth Evans; Fiona J Gilbert; Elisabeth Bergers; Petrina A Causer; Harry J de Koning
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1458-68.
2012: N Horeweg; J-W J Lammers; W Mali; Kristiaan Nackaerts; M Oudkerk; Rob J van Klaveren; C Weenink; H J M Groen; Harry J de Koning
Blinded and uniform cause of death verification in a lung cancer CT screening trial.
Lung cancer (Amsterdam, Netherlands) 2012;77(3):522-5.
2012: E M Wever; Chris H Bangma; Gerrit Draisma; E A M Heijnsdijk; Jonas Hugosson; Harry J de Koning
To be screened or not to be screened? Modeling the consequences of PSA screening for the individual.
British journal of cancer 2012;107(5):778-84.
2012: E A M Heijnsdijk; Jonas Hugosson; Ida J Korfage; Maciej Kwiatkowski; Tuukka Mäkinen; Sue Moss; Vera Nelen; Suzie J Otto; Alvaro Páez; Monique J Roobol; Fritz H Schröder; Teuvo L J Tammela; Arnauld Villers; Elisabeth M Wever; Marco Zappa; Anssi Auvinen; Chris H Bangma; Sigrid Carlsson; Stefano Ciatto; Gerrit Draisma; Marie-Louise Essink-Bot; Harry J de Koning
Quality-of-life effects of prostate-specific antigen screening.
The New England journal of medicine 2012;367(7):595-605.
2012: Susan C van 't Westeinde; René M Vernhout; Carla Weenink; Harry J de Koning; Harry J M Groen; Nanda Horeweg; Jan-Willem J Lammers; Willem Mali; Kristiaan Nackaerts; Matthijs Oudkerk; Frederik B Thunnissen; Rob J van Klaveren
The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.
Chest 2012;142(2):377-84.
2012: C M van der Aalst; C A van Iersel; Rob J van Klaveren; P A de Jong; Jacques Fracheboud; F J M Frenken; Suzie J Otto; M Oudkerk; Harry J de Koning
Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
Lung cancer (Amsterdam, Netherlands) 2012;77(1):51-7.
2012: Roman Gulati; E A M Heijnsdijk; Jeffrey Katcher; Angela B Mariotto; Alexander Tsodikov; Elisabeth M Wever; Harry J de Koning; Ruth Etzioni
The impact of PLCO control arm contamination on perceived PSA screening efficacy.
Cancer causes & control : CCC 2012;23(6):827-35.
2012: Nicolien T van Ravesteyn; Oguzhan Alagoz; Diana S M Buist; E A M Heijnsdijk; Hui Huang; Karla Kerlikowske; Sandra J Lee; Jeanne S Mandelblatt; Diana L Miglioretti; Aimee M Near; Heidi D Nelson; Clyde B Schechter; Natasha K Stout; Amy Trentham-Dietz; Harry J de Koning
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
Annals of internal medicine 2012;156(9):609-17.
2012: Carlijn M van der Aalst; Harry J de Koning; Karien A M van den Bergh; Marc C Willemsen; Rob J van Klaveren
The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial.
Lung cancer (Amsterdam, Netherlands) 2012;76(2):204-10.
2012: Suresh H Moolgavkar; Frank Schultz; Robert Boer; Lauren Clarke; Harry J de Koning; Millenia Foy; G Scott Gazelle; Olga Gorlova; William D Hazelton; Theodore R Holford; Jihyoun Jeon; Marek Kimmel; Chung Yin Kong; David T Levy; William McCarthy; Pamela M McMahon; Rafael Meza; Eric J Feuer
Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.
Journal of the National Cancer Institute 2012;104(7):541-8.
2012: Ashna D Mohangoo; Henriëtte A Moll; Johannes C van der Wouden; Johan C de Jongste; Harry J de Koning; Albert Hofman; Vincent W V Jaddoe; Jeanne M Landgraf; Johan P Mackenbach; Hein Raat
Asthma-like symptoms in the first year of life and health-related quality of life at age 12 months: the Generation R study.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(3):545-54.
2012: Fritz H Schröder; Ulf-Hakan Stenman; Kimmo Taari; Teuvo L J Tammela; Theodorus van der Kwast; Arnauld Villers; Marco Zappa; Gunnar Aus; Anssi Auvinen; Chris H Bangma; Bert G Blijenberg; Sigrid Carlsson; Stefano Ciatto; Harry J de Koning; Louis J Denis; Matti Hakama; Andreas Huber; Jonas Hugosson; Paula M Kujala; Maciej Kwiatkowski; Hans Lilja; Marcos Lujan; Liisa Määttänen; Sue Moss; Vera Nelen; Alvaro Páez; Xavier Rebillard; Franz Recker; Monique J Roobol
Prostate-cancer mortality at 11 years of follow-up.
The New England journal of medicine 2012;366(11):981-90.
2012: Peter C Jacobs; Harry J de Koning; Martijn J A Gondrie; Ivana Isgum; Yolanda van der Graaf; Bram van Ginneken; Willem P T M Mali
Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer.
AJR. American journal of roentgenology 2012;198(3):505-11.
2012: Eveline C F M Louwers; Marjo J Affourtit; Harry J de Koning; Ida J Korfage; Henriëtte A Moll
Facilitators and barriers to screening for child abuse in the emergency department.
BMC pediatrics 2012;12():167.
2012: Sepideh Saadatmand; Margreet S Schlooz-Vries; Caroline Seynaeve; Harry J de Koning; E A M Heijnsdijk; Linetta B Koppert; Inge-Marie Obdeijn; Jan C Oosterwijk; Emiel J T Rutgers; Cees Verhoef; Harmine M Zonderland; Margreet G E M Ausems; Kristien B M I Keymeulen; R A E M Tollenaar; Madeleine M A Tilanus-Linthorst
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.
BMC cancer 2012;12():440.
2012: Bart Klijs; Jan J Lous; Suzie J Otto; Yolanda van der Graaf; Robert J Heine; Harry J de Koning
Screening for type 2 diabetes in a high-risk population: study design and feasibility of a population-based randomized controlled trial.
BMC public health 2012;12():671.
2012: Susanna M van Aalten; Eric A P Steegers; Ewout W Steyerberg; Türkan Terkivatan; Mirelle E E Bröker; J J V Busschbach; Harry J de Koning; Robert A de Man; Jan N M Ijzermans
Pregnancy and liver adenoma management: PALM-study.
BMC gastroenterology 2012;12():82.
2012: Suzie J Otto; Jacqueline C I Y Reijerink-Verheij; André L M Verbeek; Rob Boer; M J M Broeders; Harry J de Koning; Jacques Fracheboud; Johannes D M Otten
Mammography screening and risk of breast cancer death: a population-based case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(1):66-73.
2011: Onno M Mets; Matthijs Oudkerk; Mathias Prokop; Bram van Ginneken; Rob J van Klaveren; Rozemarijn Vliegenthart; Pieter Zanen; Harry J de Koning; Hester A Gietema; Ivana Isgum; Jan-Willem J Lammers; Willem P Th M Mali; Constantinus F M Buckens; Pim A de Jong
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
JAMA : the journal of the American Medical Association 2011;306(16):1775-81.
2011: Susan C van't Westeinde; Rene Vernhout; Carla Weenink; Harry J de Koning; Harry J M Groen; Jan-Willem J Lammers; Willem Mali; Kristiaan Nackaerts; Matthijs Oudkerk; Frederik B Thunnissen; Rob J van Klaveren
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(10):1704-12.
2011: N T van Ravesteyn; Gerrit Draisma; E A M Heijnsdijk; Harry J de Koning
Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.
British journal of cancer 2011;105(7):1082-8.
2011: Rianne de Gelder; M J M Broeders; Gerard den Heeten; Gerrit Draisma; Jacques Fracheboud; E A M Heijnsdijk; André L M Verbeek; Harry J de Koning
Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
Preventive medicine 2011;53(3):134-40.
2011: Xiaoye Zhu; Fritz H Schröder; Pim J van Leeuwen; Chris H Bangma; Meelan Bul; Harry J de Koning; Suzie J Otto; Monique J Roobol
Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
European urology 2011;60(2):330-6.
2011: H M H J D Schoonen; E A P Steegers; Heleen M E van Agt; Hajo I J Wildschut; Marie-Louise Essink-Bot; Harry J de Koning
Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?
Patient education and counseling 2011;84(2):265-70.
2011: Rianne de Gelder; Gerrit Draisma; Jacques Fracheboud; Eveline A M Heijnsdijk; Nicolien T van Ravesteyn; Harry J de Koning
Interpreting overdiagnosis estimates in population-based mammography screening.
Epidemiologic reviews 2011;33(1):111-21.
2011: K A M van den Bergh; Rob J van Klaveren; Gerard J J M Borsboom; Marie-Louise Essink-Bot; E T Scholten; Harry J de Koning
Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.
The European respiratory journal 2011;38(1):154-61.
2011: Angela M Tjiam; Maartje De Graaf; Harry J de Koning; Johanna H Groenewoud; W Christina Hoogeveen; Rikard E Juttmann; V Kathleen Lantau; Sjoukje E Loudon; Jan Passchier; Huibert J Simonsz
Determinants and outcome of unsuccessful referral after positive screening in a large birth-cohort study of population-based vision screening.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus 2011;15(3):256-62.
2011: H M H J D Schoonen; Marie-Louise Essink-Bot; Heleen M E van Agt; Hajo I J Wildschut; E A P Steegers; Harry J de Koning
Informed decision-making about the fetal anomaly scan: what knowledge is relevant?
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2011;37(6):649-57.
2011: C M van der Aalst; Rob J van Klaveren; K A M van den Bergh; Marc C Willemsen; Harry J de Koning
The impact of a lung cancer computed tomography screening result on smoking abstinence.
The European respiratory journal 2011;37(6):1466-73.
2011: Roman Gulati; Elisabeth M Wever; Alexander Tsodikov; David F Penson; Lurdes Y T Inoue; Jeffrey Katcher; Shih-Yuan Lee; E A M Heijnsdijk; Gerrit Draisma; Harry J de Koning; Ruth Etzioni
What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(5):740-50.
2011: Eveline C F M Louwers; Ida J Korfage; Marjo J Affourtit; Dop J H Scheewe; Marjolijn H van de Merwe; Francoise A F S R Vooijs-Moulaert; Claire M C Woltering; Mieke H T M Jongejan; Madelon Ruige; Henriëtte A Moll; Harry J de Koning
Detection of child abuse in emergency departments: a multi-centre study.
Archives of disease in childhood 2011;96(5):422-5.
2011: R de Gelder; Gerrit Draisma; E A M Heijnsdijk; Harry J de Koning
Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths.
British journal of cancer 2011;104(7):1214-20.
2011: Nicolien T van Ravesteyn; Clyde Schechter; Aimee M Near; Eveline A M Heijnsdijk; Michael A Stoto; Gerrit Draisma; Harry J de Koning; Jeanne S Mandelblatt
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(1):112-22.
2010: Adriana J Rijnsburger; Inge-Marie Obdeijn; Reini Kaas; Madeleine M A Tilanus-Linthorst; Carla Boetes; Claudette E Loo; Martin N J M Wasser; Elisabeth Bergers; Theo Kok; Sara H Muller; Hans L Peterse; R A E M Tollenaar; Nicoline Hoogerbrugge; Sybren Meijer; C C M Bartels; Caroline Seynaeve; Maartje J Hooning; Mieke Kriege; Paul I M Schmitz; Jan C Oosterwijk; Harry J de Koning; E J Th Rutgers; Jan G M Klijn
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(36):5265-73.
2010: Karien A M van den Bergh; Marie-Louise Essink-Bot; Rob J van Klaveren; Harry J de Koning
Informed decision making does not affect health-related quality of life in lung cancer screening (NELSON trial).
European journal of cancer (Oxford, England : 1990) 2010;46(18):3300-6.
2010: Patrik Finne; Mahdi Fallah; Matti Hakama; Stefano Ciatto; Jonas Hugosson; Harry J de Koning; Sue Moss; Vera Nelen; Anssi Auvinen
Lead-time in the European Randomised Study of Screening for Prostate Cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(17):3102-8.
2010: Suzie J Otto; P J van Leeuwen; J W Hoekstra; J W Merckelbach; J H M Blom; Fritz H Schröder; Monique J Roobol; Harry J de Koning
Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?
European journal of cancer (Oxford, England : 1990) 2010;46(17):3061-7.
2010: Suzie J Otto; Sue Moss; L Määttänen; Monique J Roobol; M Zappa; Vera Nelen; Maciej Kwiatkowski; Arnauld Villers; Jonas Hugosson; A Berenguer Sanchez; Harry J de Koning
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(17):3053-60.
2010: Anssi Auvinen; Harry J de Koning; J-W Coebergh
Foreword: meeting the challenge of prostate cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(17):3037-9.
2010: Mirjam P Fransen; Marleen Schoonen; Johan P Mackenbach; Eric A P Steegers; Harry J de Koning; Jacqueline A M Laudy; R J H Galjaard; Caspar W N Looman; Marie-Louise Essink-Bot; Hajo I J Wildschut
Ethnic differences in participation in prenatal screening for Down syndrome: a register-based study.
Prenatal diagnosis 2010;30(10):988-94.
2010: C M van der Aalst; Rob J van Klaveren; Harry J de Koning
Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity?
Best practice & research. Clinical gastroenterology 2010;24(4):465-78.
2010: Harry J de Koning
Are low- and middle-income countries becoming the victim of Western debates about breast screening?
The breast journal 2010;16(4):442-4.
2010: Johanna H Groenewoud; Angela M Tjiam; V Kathleen Lantau; W Christina Hoogeveen; Jan-Tjeerd H N de Faber; Rikard E Juttmann; Harry J de Koning; Huibert J Simonsz
Rotterdam AMblyopia screening effectiveness study: detection and causes of amblyopia in a large birth cohort.
Investigative ophthalmology & visual science 2010;51(7):3476-84.
2010: Eleonora Baecke; Harry J de Koning; Suzie J Otto; Carola A van Iersel; Rob J van Klaveren
Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).
Lung cancer (Amsterdam, Netherlands) 2010;69(1):66-70.
2010: Ashna D Mohangoo; Harry J de Koning; Esther Hafkamp-de Groen; Johannes C van der Wouden; Vincent W V Jaddoe; Henriëtte A Moll; Albert Hofman; Johan P Mackenbach; Johan C de Jongste; Hein Raat
A comparison of parent-reported wheezing or shortness of breath among infants as assessed by questionnaire and physician-interview: The Generation R study.
Pediatric pulmonology 2010;45(5):500-7.
2010: Peter C Jacobs; Mathias Prokop; Yolanda van der Graaf; Martijn J Gondrie; Kristel J Janssen; Harry J de Koning; Ivana Isgum; Rob J van Klaveren; Matthijs Oudkerk; Bram van Ginneken; Willem P Mali
Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers.
Atherosclerosis 2010;209(2):455-62.
2010: Elisabeth M Wever; Gerrit Draisma; E A M Heijnsdijk; Monique J Roobol; Rob Boer; Suzie J Otto; Harry J de Koning
Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.
Journal of the National Cancer Institute 2010;102(5):352-5.
2010: Johannes D M Otten; M J M Broeders; Gerard J den Heeten; Roland Holland; Jacques Fracheboud; Harry J de Koning; André L M Verbeek
Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program.
Cancer 2010;116(3):586-91.
2010: K A M van den Bergh; Marie-Louise Essink-Bot; Gerard J J M Borsboom; E Th Scholten; Mathias Prokop; Harry J de Koning; Rob J van Klaveren
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).
British journal of cancer 2010;102(1):27-34.
2010: Pim J van Leeuwen; Ries Kranse; Timo Hakulinen; Monique J Roobol; Harry J de Koning; Chris H Bangma; Fritz H Schröder
Disease-specific mortality may underestimate the total effect of prostate cancer screening.
Journal of medical screening 2010;17(4):204-10.
2010: Esther Hafkamp-de Groen; Ashna D Mohangoo; Johan C de Jongste; Johannes C van der Wouden; Henriëtte A Moll; Vincent W V Jaddoe; Albert Hofman; Harry J de Koning; Hein Raat
Early detection and counselling intervention of asthma symptoms in preschool children: study design of a cluster randomised controlled trial.
BMC public health 2010;10():555.
2010: Eveline M Bunge; Esther W de Bekker-Grob; Frans C van Biezen; Marie-Louise Essink-Bot; Harry J de Koning
Patients' preferences for scoliosis brace treatment: a discrete choice experiment.
Spine 2010;35(1):57-63.
2009: Rob J van Klaveren; Matthijs Oudkerk; Mathias Prokop; Ernst T Scholten; Kristiaan Nackaerts; Rene Vernhout; Carola A van Iersel; Karien A M van den Bergh; Susan van 't Westeinde; Carlijn van der Aalst; Erik Thunnissen; Dong Ming Xu; Ying Wang; Yingru Zhao; Hester A Gietema; Bart-Jan de Hoop; Harry J M Groen; Geertruida H de Bock; Peter van Ooijen; Carla Weenink; Johny Verschakelen; Jan-Willem J Lammers; Wim Timens; Dik Willebrand; Aryan Vink; Willem Mali; Harry J de Koning
Management of lung nodules detected by volume CT scanning.
The New England journal of medicine 2009;361(23):2221-9.
2009: E A M Heijnsdijk; A der Kinderen; E M Wever; Gerrit Draisma; Monique J Roobol; Harry J de Koning
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer.
British journal of cancer 2009;101(11):1833-8.
2009: Monique J Roobol; Marjan Kerkhof; Fritz H Schröder; Jack Cuzick; Peter Sasieni; Matti Hakama; Ulf-Hakan Stenman; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis Denis; Franz Recker; Antonio Berenguer; Mirja Ruutu; Paula Kujala; Chris H Bangma; Gunnar Aus; Teuvo L J Tammela; Arnauld Villers; Xavier Rebillard; Sue Moss; Harry J de Koning; Jonas Hugosson; Anssi Auvinen
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
European urology 2009;56(4):584-91.
2009: K A M van den Bergh; Marie-Louise Essink-Bot; Rob J van Klaveren; Harry J de Koning
Informed participation in a randomised controlled trial of computed tomography screening for lung cancer.
The European respiratory journal 2009;34(3):711-20.
2009: Anssi Auvinen; Jani Raitanen; Sue Moss; Harry J de Koning; Jonas Hugosson; T Tammela; Monique Roobol; Hans Lilja; Matti Hakama
Test sensitivity in the European prostate cancer screening trial: results from Finland, Sweden, and the Netherlands.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(7):2000-5.
2009: Dong Ming Xu; Rob J van Klaveren; Geertruida H de Bock; Anne L M Leusveld; Monique D Dorrius; Yingru Zhao; Ying Wang; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
European journal of radiology 2009;70(3):492-8.
2009: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue Moss; Harry J de Koning; Anssi Auvinen
Screening and prostate-cancer mortality in a randomized European study.
The New England journal of medicine 2009;360(13):1320-8.
2009: Gerrit Draisma; Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Elisabeth Wever; Roman Gulati; Eric J Feuer; Harry J de Koning
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
Journal of the National Cancer Institute 2009;101(6):374-83.
2009: Lucien E M Duijm; Johanna H Groenewoud; Harry J de Koning; Jan Willem Coebergh; Mike van Beek; Marianne J H H Hooijen; Lonneke V van de Poll-Franse
Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
European journal of cancer (Oxford, England : 1990) 2009;45(5):774-81.
2009: Harry J de Koning
Testing at home--the screening of the future?
European journal of public health 2009;19(1):5-6.
2009: Rianne de Gelder; Jean-Luc Bulliard; Chris de Wolf; Jacques Fracheboud; Gerrit Draisma; Doris Schopper; Harry J de Koning
Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
European journal of cancer (Oxford, England : 1990) 2009;45(1):127-38.
2009: Dong Ming Xu; Hester J van der Zaag-Loonen; Matthijs Oudkerk; Ying Wang; Rozemarijn Vliegenthart; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Harry J de Koning; Rob J van Klaveren
Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
Radiology 2009;250(1):264-72.
2008: Eveline M Bunge; Karien A M van den Bergh; Marie-Louise Essink-Bot; Rob J van Klaveren; Harry J de Koning
High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):385-90.
2008: Lucien E M Duijm; Johanna H Groenewoud; Jacques Fracheboud; Menno L Plaisier; Rudi M H Roumen; B Martin van Ineveld; Mike van Beek; Harry J de Koning
Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005.
European radiology 2008;18(11):2390-7.
2008: Dong Ming Xu; Rob J van Klaveren; Geertruida H de Bock; Anne Leusveld; Yingru Zhao; Ying Wang; Rozemarijn Vliegenthart; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.
European journal of radiology 2008;68(2):347-52.
2008: Johannes D M Otten; M J M Broeders; Jacques Fracheboud; Suzie J Otto; Harry J de Koning; André L M Verbeek
Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006.
International journal of cancer. Journal international du cancer 2008;123(8):1929-34.
2008: Quirine Lamberts Okonkwo; Gerrit Draisma; Arno der Kinderen; Martin L Brown; Harry J de Koning
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Journal of the National Cancer Institute 2008;100(18):1290-300.
2008: Ying Wang; Rob J van Klaveren; Hester J van der Zaag-Loonen; Geertruida H de Bock; Hester A Gietema; Dong Ming Xu; Anne L M Leusveld; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program.
Radiology 2008;248(2):625-31.
2008: Rianne de Gelder; Elisabeth van As; Madeleine M A Tilanus-Linthorst; Carina C M Bartels; Rob Boer; Gerrit Draisma; Harry J de Koning
Breast cancer screening: evidence for false reassurance?
International journal of cancer. Journal international du cancer 2008;123(3):680-6.
2008: Karien A M van den Bergh; Marie-Louise Essink-Bot; Eveline M Bunge; Ernst Th Scholten; Mathias Prokop; Carola A van Iersel; Rob J van Klaveren; Harry J de Koning
Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial).
Cancer 2008;113(2):396-404.
2008: Ida J Korfage; Monique J Roobol; Harry J de Koning; Wim J Kirkels; Fritz H Schröder; Marie-Louise Essink-Bot
Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.
Urology 2008;72(1):3-9.
2008: Joaquim Gouveia; Michel P Coleman; Robert Haward; Roberto Zanetti; Matti Hakama; Josep Maria Borras; Maja Primic-Zakelj; Harry J de Koning; Luzia Travado
Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.
European journal of cancer (Oxford, England : 1990) 2008;44(10):1457-62.
2008: Lucien E M Duijm; Johanna H Groenewoud; Jacques Fracheboud; B Martin van Ineveld; R M H Roumen; Harry J de Koning
Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome.
European journal of cancer (Oxford, England : 1990) 2008;44(9):1223-8.
2008: Susan C van't Westeinde; Harry J de Koning; Dong-Ming Xu; Henk C Hoogsteden; Rob J van Klaveren
How to deal with incidentally detected pulmonary nodules less than 10mm in size on CT in a healthy person.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):151-9.
2008: Rob J van Klaveren; Matthijs Oudkerk; W P Th M Mali; Harry J de Koning
[Multi-detector CT screening for lung cancer is still to be discouraged for the time being].
Nederlands tijdschrift voor geneeskunde 2008;152(3):125-8.
2008: Eveline M Bunge; Harry J de Koning
Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial.
BMC musculoskeletal disorders 2008;9():57.
2008: Eveline M Bunge; Rikard E Juttmann; Frans C van Biezen; Huub Creemers; Alice A J M Hazebroek-Kampschreur; Bert C F Luttmer; P Auke Wiegersma; Harry J de Koning
Estimating the effectiveness of screening for scoliosis: a case-control study.
Pediatrics 2008;121(1):9-14.
2007: Heleen M E van Agt; Heleen A van der Stege; Hanneke de Ridder-Sluiter; Ludo T W Verhoeven; Harry J de Koning
A cluster-randomized trial of screening for language delay in toddlers: effects on school performance and language development at age 8.
Pediatrics 2007;120(6):1317-25.
2007: Ida J Korfage; Harry J de Koning; Marie-Louise Essink-Bot
Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(10):1627-34.
2007: Ashna D Mohangoo; Harry J de Koning; Resiti T Mangunkusumo; Hein Raat
Health-related quality of life in adolescents with wheezing attacks.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2007;41(5):464-71.
2007: Lucien E M Duijm; Johanna H Groenewoud; R M H Roumen; Harry J de Koning; Menno L Plaisier; Jacques Fracheboud
A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
Breast cancer research and treatment 2007;106(1):113-9.
2007: K Pieterse; Silvia van Dooren; Caroline Seynaeve; C C M Bartels; Adriana J Rijnsburger; Harry J de Koning; Jan G M Klijn; Thérèse van Elderen; Aad Tibben; Hugo J Duivenvoorden
Passive coping and psychological distress in women adhering to regular breast cancer surveillance.
Psycho-oncology 2007;16(9):851-8.
2007: Lucien E M Duijm; Johanna H Groenewoud; Jacques Fracheboud; Harry J de Koning
Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.
Journal of the National Cancer Institute 2007;99(15):1162-70.
2007: Mieke Kriege; Cecile T M Brekelmans; Hans L Peterse; Inge-Marie Obdeijn; Carla Boetes; Harmine M Zonderland; Sara H Muller; Theo Kok; Radu A Manoliu; A P E Besnard; Madeleine M A Tilanus-Linthorst; Caroline Seynaeve; C C M Bartels; Sybren Meijer; Jan C Oosterwijk; Nicoline Hoogerbrugge; R A E M Tollenaar; Harry J de Koning; E J Th Rutgers; Jan G M Klijn
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.
Breast cancer research and treatment 2007;102(3):357-63.
2007: Ida J Korfage; Harry J de Koning; J Dik F Habbema; Fritz H Schröder; Marie-Louise Essink-Bot
Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
BJU international 2007;99(4):801-6.
2007: Johanna H Groenewoud; Johannes D M Otten; Jacques Fracheboud; Gerrit Draisma; B Martin van Ineveld; Roland Holland; André L M Verbeek; Harry J de Koning
Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands.
Breast cancer research and treatment 2007;102(2):211-8.
2007: Resiti T Mangunkusumo; Johannes Brug; Harry J de Koning; Johan van der Lei; Hein Raat
School-based internet-tailored fruit and vegetable education combined with brief counselling increases children's awareness of intake levels.
Public health nutrition 2007;10(3):273-9.
2007: Carola A van Iersel; Harry J de Koning; Gerrit Draisma; W P Th M Mali; Ernst Th Scholten; Kristiaan Nackaerts; Mathias Prokop; J Dik F Habbema; Mathijs Oudkerk; Rob J van Klaveren
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
International journal of cancer. Journal international du cancer 2007;120(4):868-74.
2007: Heleen M E van Agt; Heleen A van der Stege; JG de Ridder-Sluiter; Harry J de Koning
Detecting language problems: accuracy of five language screening instruments in preschool children.
Developmental medicine and child neurology 2007;49(2):117-22; discussion 84.
2007: Stijn H De Vries; Renske Postma; René Raaijmakers; Stijn Roemeling; Suzie Otto; Harry J de Koning; Fritz H Schröder
Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.
European urology 2007;51(2):366-74; discussion 374.
2007: Ewout W Steyerberg; Monique J Roobol; Michael W Kattan; Theo Van der Kwast; Harry J de Koning; Fritz H Schröder
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
The Journal of urology 2007;177(1):107-12; discussion 112.
2007: Eveline M Bunge; Rikard E Juttmann; Marinus de Kleuver; Frans C van Biezen; Harry J de Koning
Health-related quality of life in patients with adolescent idiopathic scoliosis after treatment: short-term effects after brace or surgical treatment.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2007;16(1):83-9.
2006: Gerrit Draisma; Renske Postma; Fritz H Schröder; Theo Van der Kwast; Harry J de Koning
Gleason score, age and screening: modeling dedifferentiation in prostate cancer.
International journal of cancer. Journal international du cancer 2006;119(10):2366-71.
2006: Dong Ming Xu; Hester A Gietema; Harry J de Koning; René Vernhout; Kristiaan Nackaerts; Mathias Prokop; Carla Weenink; Jan-Willem J Lammers; Harry Groen; Matthijs Oudkerk; Rob J van Klaveren
Nodule management protocol of the NELSON randomised lung cancer screening trial.
Lung cancer (Amsterdam, Netherlands) 2006;54(2):177-84.
2006: Mieke Kriege; Cecile T M Brekelmans; Inge-Marie Obdeijn; Carla Boetes; Harmine M Zonderland; Sara H Muller; Theo Kok; Radu A Manoliu; A P E Besnard; Madeleine M A Tilanus-Linthorst; Caroline Seynaeve; C C M Bartels; Reini Kaas; Sybren Meijer; Jan C Oosterwijk; Nicoline Hoogerbrugge; R A E M Tollenaar; E J Th Rutgers; Harry J de Koning; Jan G M Klijn
Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
Breast cancer research and treatment 2006;100(1):109-19.
2006: Hester A Gietema; Ying Wang; Dongming Xu; Rob J van Klaveren; Harry J de Koning; Ernst Scholten; Johny Verschakelen; Gerhard Kohl; Matthijs Oudkerk; Mathias Prokop
Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements.
Radiology 2006;241(1):251-7.
2006: Marie-Louise Essink-Bot; Adriana J Rijnsburger; Silvia van Dooren; Harry J de Koning; Caroline Seynaeve
Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.
Breast (Edinburgh, Scotland) 2006;15(5):673-6.
2006: Suzie J Otto; Fritz H Schröder; Harry J de Koning
Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4184-9.
2006: Ida J Korfage; Tony Hak; Harry J de Koning; Marie-Louise Essink-Bot
Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study.
Social science & medicine (1982) 2006;63(4):911-9.
2006: Adriana J Rijnsburger; Marie-Louise Essink-Bot; E van As; J Cockburn; Harry J de Koning
Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(5):933-40.
2006: Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; Sara H Muller; Harmine M Zonderland; Inge-Marie Obdeijn; Radu A Manoliu; Theo Kok; E J Th Rutgers; Harry J de Koning; Jan G M Klijn
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Cancer 2006;106(11):2318-26.
2006: Ida J Korfage; Marie-Louise Essink-Bot; A Cecile J W Janssens; Fritz H Schröder; Harry J de Koning
Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up.
British journal of cancer 2006;94(8):1093-8.
2006: Jacques Fracheboud; Johanna H Groenewoud; Rob Boer; Gerrit Draisma; Arry E de Bruijn; André L M Verbeek; Harry J de Koning
Seventy-five years is an appropriate upper age limit for population-based mammography screening.
International journal of cancer. Journal international du cancer 2006;118(8):2020-5.
2006: Eveline M Bunge; Harry J de Koning
Selective screening for scoliosis.
Clinical orthopaedics and related research 2006;445():277-8; author reply 278-9.
2006: Resiti T Mangunkusumo; Joop S Duisterhout; Nijs de Graaff; Erik J Maarsingh; Harry J de Koning; Hein Raat
Internet versus paper mode of health and health behavior questionnaires in elementary schools: asthma and fruit as examples.
The Journal of school health 2006;76(2):80-6.
2006: Sita Y G L Tan; Gerrit J van Oortmarssen; Harry J de Koning; Rob Boer; J Dik F Habbema
The MISCAN-Fadia continuous tumor growth model for breast cancer.
Journal of the National Cancer Institute. Monographs 2006;(36):56-65.
2006: Eveline M Bunge; Rikard E Juttmann; Harry J de Koning
Screening for scoliosis: do we have indications for effectiveness?
Journal of medical screening 2006;13(1):29-33.
2006: Harry J de Koning; Gerrit Draisma; Jacques Fracheboud; Arry de Bruijn
Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.
Breast cancer research : BCR 2006;8(1):202.
2006: Ida J Korfage; Harry J de Koning; Monique J Roobol; Fritz H Schröder; Marie-Louise Essink-Bot
Prostate cancer diagnosis: the impact on patients' mental health.
European journal of cancer (Oxford, England : 1990) 2006;42(2):165-70.
2005: Arja R Aro; Harry J de Koning; Marjut Schreck; M Henriksson; A Anttila; E Pukkala
Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland.
Psychological medicine 2005;35(10):1515-21.
2005: Ashna D Mohangoo; Marie-Louise Essink-Bot; Elizabeth F Juniper; Henriëtte A Moll; Harry J de Koning; Hein Raat
Health-related quality of life in preschool children with wheezing and dyspnea: preliminary results from a random general population sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(8):1931-6.
2005: Ida J Korfage; Marie-Louise Essink-Bot; Gerard J J M Borsboom; Joanna B Madalinska; Wim J Kirkels; J Dik F Habbema; Fritz H Schröder; Harry J de Koning
Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.
International journal of cancer. Journal international du cancer 2005;116(2):291-6.
2005: Madeleine M A Tilanus-Linthorst; Mieke Kriege; Carla Boetes; Wim C J Hop; Inge-Marie Obdeijn; Jan C Oosterwijk; Hans L Peterse; Harmine M Zonderland; Sybren Meijer; Alexander M M Eggermont; Harry J de Koning; Jan G M Klijn; Cecile T M Brekelmans
Hereditary breast cancer growth rates and its impact on screening policy.
European journal of cancer (Oxford, England : 1990) 2005;41(11):1610-7.
2005: Ingrid W van der Cruijsen-Koeter; André N Vis; Monique J Roobol; Mark F Wildhagen; Harry J de Koning; Theo Van der Kwast; Fritz H Schröder
Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.
The Journal of urology 2005;174(1):121-5.
2005: Silvia van Dooren; Caroline Seynaeve; Adriana J Rijnsburger; Hugo J Duivenvoorden; Marie-Louise Essink-Bot; Madeleine M A Tilanus-Linthorst; Jan G M Klijn; Harry J de Koning; Aad Tibben
Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(10):1416-25.
2005: Heleen M E van Agt; Marie-Louise Essink-Bot; Heleen A van der Stege; JG de Ridder-Sluiter; Harry J de Koning
Quality of life of children with language delays.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(5):1345-55.
2005: Johannes D M Otten; Nico Karssemeijer; J H C L Hendriks; Johanna H Groenewoud; Jacques Fracheboud; André L M Verbeek; Harry J de Koning; Roland Holland
Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Journal of the National Cancer Institute 2005;97(10):748-54.
2005: Fritz H Schröder; Monique J Roobol; Ronald A M Damhuis; Harry J de Koning; Bert G Blijenberg; Theo Van der Kwast; Wim J Kirkels; Chris H Bangma
Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years.
Journal of the National Cancer Institute 2005;97(9):696.
2005: Harry J de Koning
Errors in "family" practice.
Lancet 2005;365(9463):1001.
2005: Silvia van Dooren; Caroline Seynaeve; Adriana J Rijnsburger; Hugo J Duivenvoorden; Marie-Louise Essink-Bot; C C M Bartels; Jan G M Klijn; Harry J de Koning; Aad Tibben
The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer.
Breast cancer research and treatment 2005;89(1):75-80.
2005: Resiti T Mangunkusumo; Peter W Moorman; Annelette E Van Den Berg-de Ruiter; Johan van der Lei; Harry J de Koning; Hein Raat
Internet-administered adolescent health questionnaires compared with a paper version in a randomized study.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2005;36(1):70.e1-6.
2004: Lucien E M Duijm; Johanna H Groenewoud; F H Jansen; Jacques Fracheboud; M van Beek; Harry J de Koning
Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening.
British journal of cancer 2004;91(10):1795-9.
2004: Silvia van Dooren; Adriana J Rijnsburger; Caroline Seynaeve; Hugo J Duivenvoorden; Marie-Louise Essink-Bot; Madeleine M A Tilanus-Linthorst; Harry J de Koning; Aad Tibben
Psychological distress in women at increased risk for breast cancer: the role of risk perception.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2056-63.
2004: Jacques Fracheboud; Suzie J Otto; J A A M van Dijck; M J M Broeders; André L M Verbeek; Harry J de Koning
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands.
British journal of cancer 2004;91(5):861-7.
2004: Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; Peter E Besnard; Harmine M Zonderland; Inge-Marie Obdeijn; Radu A Manoliu; Theo Kok; Hans L Peterse; Madeleine M A Tilanus-Linthorst; Sara H Muller; Sybren Meijer; Jan C Oosterwijk; Louk V A M Beex; R A E M Tollenaar; Harry J de Koning; E J Th Rutgers; Jan G M Klijn
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
The New England journal of medicine 2004;351(5):427-37.
2004: Monica Vervoort; Gerrit Draisma; Jacques Fracheboud; Lonneke V van de Poll-Franse; Harry J de Koning
Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.
British journal of cancer 2004;91(2):242-7.
2004: Adriana J Rijnsburger; Gerrit J van Oortmarssen; Rob Boer; Gerrit Draisma; Teresa To; Anthony B Miller; Harry J de Koning
Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation.
International journal of cancer. Journal international du cancer 2004;110(5):756-62.
2004: Adriana J Rijnsburger; Marie-Louise Essink-Bot; Silvia van Dooren; Gerard J J M Borsboom; Caroline Seynaeve; C C M Bartels; Jan G M Klijn; Aad Tibben; Harry J de Koning
Impact of screening for breast cancer in high-risk women on health-related quality of life.
British journal of cancer 2004;91(1):69-76.
2004: Suzie J Otto; Harry J de Koning
Update on screening and early detection of prostate cancer.
Current opinion in urology 2004;14(3):151-6.
2004: Lucien E M Duijm; Johanna H Groenewoud; J H C L Hendriks; Harry J de Koning
Independent double reading of screening mammograms in The Netherlands: effect of arbitration following reader disagreements.
Radiology 2004;231(2):564-70.
2004: Monique J Roobol; Ries Kranse; Harry J de Koning; Fritz H Schröder
Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
Urology 2004;63(2):309-13; discussion 313-5.
2004: Johanna H Groenewoud; RM Pijnappel; Elske van den Akker; E Birnie; Tineke Buijs-Van der Woude; W P Th M Mali; Harry J de Koning; Erik Buskens
Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.
British journal of cancer 2004;90(2):383-92.
2004: Karin Flobbe; Alfons G H Kessels; Johan L Severens; Geerard L Beets; Harry J de Koning; Maarten F von Meyenfeld; Jos M A van Engelshoven
Costs and effects of ultrasonography in the evaluation of palpable breast masses.
International journal of technology assessment in health care 2004;20(4):440-8.
2004: Harry J de Koning; JG de Ridder-Sluiter; Heleen M E van Agt; C M M Reep-van den Bergh; Heleen A van der Stege; Ida J Korfage; Johan J Polder; Paul J van der Maas
A cluster-randomised trial of screening for language disorders in toddlers.
Journal of medical screening 2004;11(3):109-16.
2004: Suzie J Otto; Fritz H Schröder; Harry J de Koning
Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
Journal of medical screening 2004;11(2):89-92.
2003: Harry J de Koning; T Hakulinen; Sue Moss; J Adolfsson; P H Smith; F E Alexander
Monitoring the ERSPC trial.
BJU international 2003;92 Suppl 2():112-4.
2003: Gerrit Draisma; Harry J de Koning
MISCAN: estimating lead-time and over-detection by simulation.
BJU international 2003;92 Suppl 2():106-11.
2003: Marie-Louise Essink-Bot; Ida J Korfage; Harry J de Koning
Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
BJU international 2003;92 Suppl 2():101-5.
2003: Harry J de Koning; J Blom; J W Merkelbach; René Raaijmakers; H Verhaegen; P Van Vliet; Vera Nelen; Dorry Boll; A Hermans; Stefano Ciatto; T Mäkinen
Determining the cause of death in randomized screening trial(s) for prostate cancer.
BJU international 2003;92 Suppl 2():71-8.
2003: Harry J de Koning
Why improvement in survival of screen-detected cases is not necessarily equivalent to benefit?
Breast (Edinburgh, Scotland) 2003;12(5):299-301.
2003: Harry J de Koning
Mammographic screening: evidence from randomised controlled trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1185-9.
2003: Suzie J Otto; Ingrid W van der Cruijsen; Michael K Liem; Ida J Korfage; Jan J Lous; Fritz H Schröder; Harry J de Koning
Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
International journal of cancer. Journal international du cancer 2003;105(3):394-9.
2003: Gerrit Draisma; Rob Boer; Suzie J Otto; Ingrid W van der Cruijsen; Ronald A M Damhuis; Fritz H Schröder; Harry J de Koning
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
Journal of the National Cancer Institute 2003;95(12):868-78.
2003: Ida J Korfage; Marie-Louise Essink-Bot; Joanna B Madalinska; Wim J Kirkels; M S Litwin; Harry J de Koning
Measuring disease specific quality of life in localized prostate cancer: the Dutch experience.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(4):459-64.
2003: Suzie J Otto; Jacques Fracheboud; Caspar W N Looman; M J M Broeders; Rob Boer; J H C L Hendriks; André L M Verbeek; Harry J de Koning
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.
Lancet 2003;361(9367):1411-7.
2003: Nico Karssemeijer; Johannes D M Otten; André L M Verbeek; Johanna H Groenewoud; Harry J de Koning; J H C L Hendriks; Roland Holland
Computer-aided detection versus independent double reading of masses on mammograms.
Radiology 2003;227(1):192-200.
2003: Silvia van Dooren; Adriana J Rijnsburger; Caroline Seynaeve; A Kriege; Hugo J Duivenvoorden; C C M Bartels; Marie-Louise Essink-Bot; Harry J de Koning; Aad Tibben
Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer.
Community genetics 2003;6(4):235-41.
2002: Rob J van Klaveren; Harry J de Koning; James Mulshine; Fred R Hirsch
Lung cancer screening by spiral CT. What is the optimal target population for screening trials?
Lung cancer (Amsterdam, Netherlands) 2002;38(3):243-52.
2002: Harry J de Koning; J Fracheboud; André L M Verbeek; E J Th Rutgers; Paul J van der Maas
[The scientific basis for population screening for breast cancer in the Netherlands].
Nederlands tijdschrift voor geneeskunde 2002;146(22):1034-41.
2002: Helena M Verkooijen; E Buskens; Petra Peeters; Inne H M Borel Rinkes; Harry J de Koning; Th J M V van Vroonhoven
Diagnosing non-palpable breast disease: short-term impact on quality of life of large-core needle biopsy versus open breast biopsy.
Surgical oncology 2002;10(4):177-81.
2002: Harry J de Koning; Michael K Liem; Caroline A Baan; Rob Boer; Fritz H Schröder; Freda E Alexander
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial.
International journal of cancer. Journal international du cancer 2002;98(2):268-73.
2002: Anssi Auvinen; Freda E Alexander; Harry J de Koning; Anthony B Miller
Should we start population screening for prostate cancer? Randomised trials are still needed.
International journal of cancer. Journal international du cancer 2002;97(3):377-8.
2002: Harry J de Koning; Anssi Auvinen; Antonio Berenguer Sanchez; Fernando Calais da Silva; Stefano Ciatto; Louis Denis; John K Gohagan; Matti Hakama; Jonas Hugosson; Ries Kranse; Vera Nelen; Philip C Prorok; Fritz H Schröder
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
International journal of cancer. Journal international du cancer 2002;97(2):237-44.
2001: Arja R Aro; Harry J de Koning; Pilvikki Absetz; Marjut Schreck
Two distinct groups of non-attenders in an organized mammography screening program.
Breast cancer research and treatment 2001;70(2):145-53.
2001: Rob J van Klaveren; J H Pedersen; Harry J de Koning; M Oudkerk; Henk C Hoogsteden
Lung cancer screening by low-dose spiral computed tomography.
The European respiratory journal 2001;18(5):857-66.
2001: Anthony B Miller; Joanna B Madalinska; T Church; D Crawford; Marie-Louise Essink-Bot; V Goel; Harry J de Koning; L Määttänen; T Pentikäinen
Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.
European journal of cancer (Oxford, England : 1990) 2001;37(17):2154-60.
2001: Ingrid W van der Cruijsen-Koeter; Mark F Wildhagen; Harry J de Koning; Fritz H Schröder
The value of current diagnostic tests in prostate cancer screening.
BJU international 2001;88(5):458-66.
2001: Robert F Hoedemaeker; Theo Van der Kwast; Rob Boer; Harry J de Koning; Monique J Roobol; André N Vis; Fritz H Schröder
Pathologic features of prostate cancer found at population-based screening with a four-year interval.
Journal of the National Cancer Institute 2001;93(15):1153-8.
2001: Rob J van Klaveren; J D Habbema; Harry J de Koning; M Oudkerk; R A Damhuis; Henk C Hoogsteden
[Screening for lung cancer in the Netherlands: the role of spiral CT scan].
Nederlands tijdschrift voor geneeskunde 2001;145(11):521-6.
2001: Joanna B Madalinska; Marie-Louise Essink-Bot; Harry J de Koning; Wim J Kirkels; Paul J van der Maas; Fritz H Schröder
Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1619-28.
2001: Jacques Fracheboud; Harry J de Koning; Rob Boer; Johanna H Groenewoud; André L M Verbeek; M J M Broeders; B Martin van Ineveld; J H C L Hendriks; AE de Bruyn; Roland Holland; Paul J van der Maas
Nationwide breast cancer screening programme fully implemented in The Netherlands.
Breast (Edinburgh, Scotland) 2001;10(1):6-11.
2001: Joanna B Madalinska; Marie-Louise Essink-Bot; Harry J de Koning; Wim J Kirkels; Paul J van der Maas; Fritz H Schröder
Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment.
The Prostate 2001;46(2):87-97.
2001: Christi J van Asperen; Geertruida H de Bock; F van der Horst; Harry J de Koning; E J Rutgers
[Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
Nederlands tijdschrift voor geneeskunde 2001;145(3):120-5.
2001: Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; E J Th Rutgers; Jan C Oosterwijk; R A E M Tollenaar; Radu A Manoliu; Roland Holland; Harry J de Koning; Jan G M Klijn
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC).
Familial cancer 2001;1(3-4):163-8.
2000: PM Beemsterboer; Harry J de Koning; Ries Kranse; PH Trienekens; Paul J van der Maas; Fritz H Schröder
Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
The Journal of urology 2000;164(4):1216-20.
2000: Madeleine M A Tilanus-Linthorst; Inge-Marie Obdeijn; Karina C M Bartels; Harry J de Koning; M Oudkerk
First experiences in screening women at high risk for breast cancer with MR imaging.
Breast cancer research and treatment 2000;63(1):53-60.
2000: Fritz H Schröder; Ingrid W van der Cruijsen-Koeter; Harry J de Koning; André N Vis; Robert F Hoedemaeker; Ries Kranse
Prostate cancer detection at low prostate specific antigen.
The Journal of urology 2000;163(3):806-12.
2000: Harry J de Koning
Assessment of nationwide cancer-screening programmes.
Lancet 2000;355(9198):80-1.
2000: Harry J de Koning
Breast cancer screening; cost-effective in practice?
European journal of radiology 2000;33(1):32-7.
1999: Jacques Fracheboud; Harry J de Koning; PM Beemsterboer; Rob Boer; André L M Verbeek; J H C L Hendriks; B Martin van Ineveld; M J M Broeders; AE de Bruyn; Paul J van der Maas
Interval cancers in the Dutch breast cancer screening programme.
British journal of cancer 1999;81(5):912-7.
1999: Rob Boer; Harry J de Koning; Paul J. van der Maas
A longer breast carcinoma screening interval for women age older than 65 years?
Cancer 1999;86(8):1506-10.
1999: PM Beemsterboer; Ries Kranse; Harry J de Koning; J Dik F Habbema; Fritz H Schröder
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).
International journal of cancer. Journal international du cancer 1999;84(4):437-41.
1999: PM Beemsterboer; Harry J de Koning; E Birnie; Paul J van der Maas; Fritz H Schröder
Advanced prostate cancer: course, care, and cost implications.
The Prostate 1999;40(2):97-104.
1999: PM Beemsterboer; Harry J de Koning; C W Looman; Gerard J J M Borsboom; A I Bartelds; Paul J van der Maas
Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995.
European journal of cancer (Oxford, England : 1990) 1999;35(3):450-4.
1999: Rob Boer; Harry J de Koning; Gerrit J van Oortmarssen; PG Warmerdam; Paul J van der Maas
Stage distribution at first and repeat examinations in breast cancer screening.
Journal of medical screening 1999;6(3):132-8.
1999: H A van Leiden; A A van Gessel-Dabekaussen; Paul J van der Maas; Harry J de Koning
Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands.
Journal of medical screening 1999;6(2):94-8.
1999: Arja R Aro; Harry J de Koning; Pilvikki Absetz; Marjut Schreck
Psychosocial predictors of first attendance for organised mammography screening.
Journal of medical screening 1999;6(2):82-8.
1999: Elske van den Akker; Harry J de Koning; Rob Boer; Paul J van der Maas
Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom.
Journal of medical screening 1999;6(1):30-4.
1998: Harry J de Koning; F H Schröder
PSA screening for prostate cancer: the current controversy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(12):1293-6.
1998: S Shapiro; E A Coleman; M J M Broeders; M Codd; Harry J de Koning; Jacques Fracheboud; Sue Moss; E Paci; S Stachenko; Rachel Ballard-Barbash
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening.
International journal of epidemiology 1998;27(5):735-42.
1998: Rob Boer; Harry J de Koning; A Threlfall; PG Warmerdam; Andrew Street; E Friedman; Ciaran B J Woodman
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
BMJ (Clinical research ed.) 1998;317(7155):376-9.
1998: Marie-Louise Essink-Bot; Harry J de Koning; HG Nijs; Wim J Kirkels; Paul J van der Maas; Fritz H Schröder
Short-term effects of population-based screening for prostate cancer on health-related quality of life.
Journal of the National Cancer Institute 1998;90(12):925-31.
1998: Jacques Fracheboud; Harry J de Koning; PM Beemsterboer; Rob Boer; J H C L Hendriks; André L M Verbeek; B Martin van Ineveld; AE de Bruyn; Paul J van der Maas
Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.
International journal of cancer. Journal international du cancer 1998;75(5):694-8.
1998: PM Beemsterboer; PG Warmerdam; Rob Boer; Harry J de Koning
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?
Journal of medical screening 1998;5(2):81-7.
1998: J M Borràs; JA Espinas; P M Beemsterboer; A Granados; Harry J de Koning
Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making.
International journal of technology assessment in health care 1998;14(2):268-76.
1997: J A van Dongen; Dorry Boll; Harry J de Koning
[The relationship between health gain and effort in mass screening for breast cancer].
Nederlands tijdschrift voor geneeskunde 1997;141(47):2277-80.
1997: Elske van den Akker; C M Reep-van den Bergh; Rob Boer; A Del Moral; N Ascunce; Harry J de Koning
Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.
International journal of cancer. Journal international du cancer 1997;73(4):464-9.
1997: Rob Boer; Harry J de Koning; PM Beemsterboer; PG Warmerdam; F H Schroeder
A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer.
The Journal of urology 1997;157(5):1768-71; discussion 1771-2.
1997: PG Warmerdam; Harry J de Koning; Rob Boer; PM Beemsterboer; ML Dierks; Enno Swart; Bernt-Peter Robra
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
Journal of epidemiology and community health 1997;51(2):180-6.
1997: JB Rietbergen; Ries Kranse; Wim J Kirkels; Harry J de Koning; Fritz H Schröder
Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.
British journal of urology 1997;79 Suppl 2():57-63.
1996: Harry J de Koning; Dorry Boll; J A van Dongen
Is mass screening for breast cancer cost-effective?
European journal of cancer (Oxford, England : 1990) 1996;32A(11):1835-44.
1996: R E Juttmann; Harry J de Koning; J F Meulmeester; Paul J van der Maas
[Published effects of screening in parental and child health care].
Nederlands tijdschrift voor geneeskunde 1996;140(25):1303-7.
1996: F H Shröder; R A Damhuis; Wim J Kirkels; Harry J de Koning; Ries Kranse; H G Nus; Bert G Blijenberg
European randomized study of screening for prostate cancer--the Rotterdam pilot studies.
International journal of cancer. Journal international du cancer 1996;65(2):145-51.
1996: Rob Boer; G J van Oortmarssen; Harry J de Koning
Cost-effectiveness of mammography screening.
JAMA : the journal of the American Medical Association 1996;275(2):111-2.
1995: Rob Boer; Harry J de Koning; Gerrit J van Oortmarssen; Paul J van der Maas
In search of the best upper age limit for breast cancer screening.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):2040-3.
1995: Harry J de Koning; Rob Boer; PG Warmerdam; PM Beemsterboer; Paul J van der Maas
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
Journal of the National Cancer Institute 1995;87(16):1217-23.
1995: Harry J de Koning
Screening for breast cancer, time to think--and stop? National Evaluation Team for Breast Cancer Screening (NETB)
Lancet 1995;346(8972):438-9.
1995: Fritz H Schröder; L J Denis; Wim J Kirkels; Harry J de Koning; B Standaert
European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.
Cancer 1995;76(1):129-34.
1995: Petronella Berns; John A Foekens; Iris L van Staveren; Wim L J van Putten; Harry J de Koning; H Portengen; Jan G M Klijn
Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment.
Gene 1995;159(1):11-8.
1995: Rob Boer; Harry J de Koning; Gerrit J van Oortmarssen; Paul J van der Maas
Screening for breast cancer. Incidence of interval cancer and detection rate of first screenings are inconsistent.
BMJ (Clinical research ed.) 1995;310(6985):1002.
1995: Harry J de Koning; Jacques Fracheboud; Rob Boer; André L M Verbeek; HJ Collette; J H C L Hendriks; B Martin van Ineveld; A E de Bruyn; Paul J van der Maas
Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).
International journal of cancer. Journal international du cancer 1995;60(6):777-80.
1995: E Paci; Rob Boer; Marco Zappa; Harry J de Koning; Gerrit J van Oortmarssen; Emanuele Crocetti; D Giorgi; Marco Rosselli Del Turco; J Dik F Habbema
A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):348-53.
1994: Harry J de Koning; J A van Dongen; Paul J van der Maas
Changes in use of breast-conserving therapy in years 1978-2000.
British journal of cancer 1994;70(6):1165-70.
1994: PM Beemsterboer; Harry J de Koning; PG Warmerdam; Rob Boer; Enno Swart; M L Dierks; Bernt-Peter Robra
Prediction of the effects and costs of breast-cancer screening in Germany.
International journal of cancer. Journal international du cancer 1994;58(5):623-8.
1994: Rob Boer; PG Warmerdam; Harry J de Koning; G van Oortmarssen
Extra incidence caused by mammographic screening.
Lancet 1994;343(8903):979.
1993: John A Foekens; Wim L J van Putten; H Portengen; Harry J de Koning; B Thirion; J Alexieva-Figusch; Jan G M Klijn
Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):899-908.
1993: R Carter; Paul Glasziou; G van Oortmarssen; Harry J de Koning; C Stevenson; Glenn Salkeld; Rob Boer
Cost-effectiveness of mammographic screening in Australia.
Australian journal of public health 1993;17(1):42-50.
1993: B Martin van Ineveld; Gerrit J van Oortmarssen; Harry J de Koning; Rob Boer; Paul J van der Maas
How cost-effective is breast cancer screening in different EC countries?
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1663-8.
1992: Harry J de Koning; B Martin van Ineveld; J C de Haes; Gerrit J van Oortmarssen; Jan G M Klijn; Paul J van der Maas
Advanced breast cancer and its prevention by screening.
British journal of cancer 1992;65(6):950-5.
1991: J C de Haes; Harry J de Koning; Gerrit J van Oortmarssen; H M van Agt; A E de Bruyn; Paul J van der Maas
The impact of a breast cancer screening programme on quality-adjusted life-years.
International journal of cancer. Journal international du cancer 1991;49(4):538-44.
1991: Harry J de Koning; B Martin van Ineveld; Gerrit J van Oortmarssen; J C de Haes; HJ Collette; J H C L Hendriks; Paul J van der Maas
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.
International journal of cancer. Journal international du cancer 1991;49(4):531-7.
1990: Harry J de Koning; Rob Boer; Paul J van der Maas; B Martin van Ineveld; HJ Collette; J H C L Hendriks
[Efficacy of mass screening for breast cancer; reduced mortality nationally and internationally].
Nederlands tijdschrift voor geneeskunde 1990;134(46):2240-5.
1990: Gerrit J van Oortmarssen; J Dik F Habbema; Paul J van der Maas; Harry J de Koning; HJ Collette; André L M Verbeek; A T Geerts; K T Lubbe
A model for breast cancer screening.
Cancer 1990;66(7):1601-12.
1990: Harry J de Koning; Gerrit J van Oortmarssen; B Martin van Ineveld; Paul J van der Maas
Breast cancer screening: its impact on clinical medicine.
British journal of cancer 1990;61(2):292-7.
1989: Paul J van der Maas; Harry J de Koning; B Martin van Ineveld; Gerrit J van Oortmarssen; J Dik F Habbema; K T Lubbe; A T Geerts; HJ Collette; André L M Verbeek; J H C L Hendriks
The cost-effectiveness of breast cancer screening.
International journal of cancer. Journal international du cancer 1989;43(6):1055-60.
1989: B J Delemarre; Cees A Visser; H Bot; Harry J de Koning; A J Dunning
Predictive value of pulsed Doppler echocardiography in acute myocardial infarction.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 1989;2(2):102-9.